Page last updated: 2024-08-23

raloxifene hydrochloride and leupeptins

raloxifene hydrochloride has been researched along with leupeptins in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Basile, I; Gallud, A; Garcia, M; Gary-Bobo, M; Maynadier, M	1
Bruzzaniti, A; Eleniste, PP; Himes, ER; Hong, JM; Kacena, MA; McIntyre, PW; Patel, V; Posritong, S; Wu, JL	1

Other Studies

2 other study(ies) available for raloxifene hydrochloride and leupeptins

Article	Year
Combination treatment with proteasome inhibitors and antiestrogens has a synergistic effect mediated by p21WAF1 in estrogen receptor-positive breast cancer. Oncology reports, 2016, Volume: 36, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinases; Drug Resistance, Neoplasm; Drug Synergism; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Leupeptins; MCF-7 Cells; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Raloxifene Hydrochloride; Receptors, Estrogen; RNA, Messenger; Tamoxifen	2016
Pyk2 deficiency potentiates osteoblast differentiation and mineralizing activity in response to estrogen or raloxifene. Molecular and cellular endocrinology, 2018, 10-15, Volume: 474 Topics: Alkaline Phosphatase; Animals; Biomarkers; Calcification, Physiologic; Cell Count; Cell Differentiation; Cell Proliferation; Cells, Cultured; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Focal Adhesion Kinase 2; Gene Deletion; Leupeptins; MAP Kinase Signaling System; Mice, Inbred C57BL; Mice, Knockout; Osteoblasts; Proteolysis; Raloxifene Hydrochloride	2018

Article

Year

Combination treatment with proteasome inhibitors and antiestrogens has a synergistic effect mediated by p21WAF1 in estrogen receptor-positive breast cancer.

Oncology reports, 2016, Volume: 36, Issue:2

Topics: Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinases; Drug Resistance, Neoplasm; Drug Synergism; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Leupeptins; MCF-7 Cells; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Raloxifene Hydrochloride; Receptors, Estrogen; RNA, Messenger; Tamoxifen

2016

Pyk2 deficiency potentiates osteoblast differentiation and mineralizing activity in response to estrogen or raloxifene.

Molecular and cellular endocrinology, 2018, 10-15, Volume: 474

Topics: Alkaline Phosphatase; Animals; Biomarkers; Calcification, Physiologic; Cell Count; Cell Differentiation; Cell Proliferation; Cells, Cultured; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Focal Adhesion Kinase 2; Gene Deletion; Leupeptins; MAP Kinase Signaling System; Mice, Inbred C57BL; Mice, Knockout; Osteoblasts; Proteolysis; Raloxifene Hydrochloride

2018